Serina Therapeutics (SER) Change in Cash (2018 - 2025)
Serina Therapeutics (SER) posted Change in Cash of -$5.6 million for Q4 2025, down 315.74% sequentially from $2.6 million in Q3 2025, and down 1373.23% YoY from $437000.0 in Q4 2024.
Serina Therapeutics (SER) Change in Cash (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Change in Cash for 8 years, with the latest figure at -$5.6 million in Q4 2025.
- Quarterly Change in Cash fell 1373.23% year-over-year to -$5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$616000.0 (up 84.39% YoY) and the FY2025 annual result came in at -$616000.0, up 84.39% from the prior year.
- Change in Cash slipped to -$5.6 million in Q4 2025 per SER's latest filing, from $2.6 million in the prior quarter.
- Over five years, Change in Cash peaked at $9.4 million in Q1 2023 and troughed at -$5.6 million in Q4 2025.
- A 5-year average of $132100.0 and a median of $77000.0 in 2021 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2025: Change in Cash soared 6997.06% in 2023, then slumped 1373.23% in 2025.
- Over 5 years, Change in Cash stood at -$147000.0 in 2021, then soared by 221.77% to $179000.0 in 2022, then tumbled by 78.77% to $38000.0 in 2023, then surged by 1050.0% to $437000.0 in 2024, then plunged by 1373.23% to -$5.6 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$5.6 million, $2.6 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.56 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 595,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Sep 30, 2024 | -2.88 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | -1.14 Mn |
| Jun 30, 2023 | -1.19 Mn |
| Mar 31, 2023 | 9.38 Mn |
| Dec 31, 2022 | 179,000.00 |
| Sep 30, 2022 | -236,000.00 |
| Jun 30, 2022 | 254,000.00 |
| Mar 31, 2022 | -136,000.00 |
| Dec 31, 2021 | -147,000.00 |
| Sep 30, 2021 | 116,000.00 |
| Jun 30, 2021 | -194,000.00 |
| Mar 31, 2021 | 282,000.00 |